Use of olanzapine to treat agitation in traumatic brain injury: study protocol for a randomised controlled trial.

Trials
Ruby K PhylandJennie Ponsford

Abstract

Agitation is common in the early stages of recovery from traumatic brain injury (TBI), when patients are in post-traumatic amnesia (PTA). Agitation is associated with risk of harm to patients and caregivers. Recent guidelines recommend that agitation during PTA is managed using environmental modifications. Agitation is also frequently treated pharmacologically, with the use of atypical antipsychotics such as olanzapine among the most common. This is despite a lack of well-designed studies to support the use of antipsychotics within this context. This study will be a double-blind, placebo-controlled randomised controlled trial. We will examine the efficacy, safety, cost-effectiveness and outcomes associated with the use of olanzapine for reducing agitation in patients in PTA following TBI over and above recommended environmental management. Fifty-eight TBI rehabilitation inpatients who are in PTA and are agitated will receive olanzapine or placebo for the duration of PTA. All participants will additionally receive optimal environmental management for agitation. Measures of agitation, PTA and health will be undertaken at baseline. Treatment administration will begin at a dose of 5 mg daily and may be escalated to a maximum dose o...Continue Reading

References

Mar 1, 1992·Brain Injury : [BI]·J D CorriganS K Chock
Mar 1, 1989·Journal of Clinical and Experimental Neuropsychology·J D Corrigan
May 26, 1986·The Medical Journal of Australia·E A ShoresJ Batchelor
Jan 1, 1970·Acta Psychiatrica Scandinavica. Supplementum·G M Simpson, J W Angus
Jun 1, 1994·Journal of Clinical and Experimental Neuropsychology·J D Corrigan, J A Bogner
Dec 1, 1996·Archives of Physical Medicine and Rehabilitation·K J OttenbacherR C Fiedler
Feb 1, 1997·Archives of Physical Medicine and Rehabilitation·W J Mysiw, M E Sandel
Aug 1, 1997·Archives of Physical Medicine and Rehabilitation·J D CorriganC V Granger
Feb 9, 1999·The Journal of Head Trauma Rehabilitation·J A BognerD Rabold
Apr 4, 2000·The Journal of Head Trauma Rehabilitation·J A BognerA W Heinemann
Aug 29, 2001·American Journal of Physical Medicine & Rehabilitation·J A BognerD Clinchot
Dec 5, 2002·Neurorehabilitation and Neural Repair·Larry B Goldstein, Sarah Bullman
Oct 21, 2003·American Journal of Physical Medicine & Rehabilitation·Margaret S WilsonRobert J Hamm
May 4, 2004·Journal of Health Economics·Melinda Beeuwkes Buntin, Alan M Zaslavsky
Oct 6, 2005·American Journal of Physical Medicine & Rehabilitation·Lisa A Lombard, Ross D Zafonte
Jan 1, 1995·Applied Neuropsychology·E A Shores
Oct 21, 2006·The Cochrane Database of Systematic Reviews·S FlemingerD L Oliver
Oct 26, 2006·Brain Injury : [BI]·Nicole WeirCollette Zemljic
Nov 25, 2006·Brain Injury : [BI]·Melissa T NottIan J Baguley
Feb 14, 2007·Behavioural Neurology·Enrique NoéJavier Chirivella
May 19, 2007·The Journal of Head Trauma Rehabilitation·Anthony H LequericaRobin A Hanks
May 10, 2008·Brain Injury : [BI]·C M CameronR J McClure
Sep 4, 2008·Neuropsychology·Kristy Draper, Jennie Ponsford
Jul 25, 2009·PM & R : the Journal of Injury, Function, and Rehabilitation·Steven R FlanaganElizabeth Sandel
Mar 25, 2010·BMJ : British Medical Journal·Kenneth F SchulzUNKNOWN CONSORT Group
Sep 14, 2010·Journal of Internal Medicine·A Mackinnon
Nov 4, 2010·Archives of Physical Medicine and Rehabilitation·Elisabeth A WildeNicole von Steinbuechel
Sep 13, 2013·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Richard NormanDeborah Street
Jan 1, 1995·NeuroRehabilitation·R McNeny, J Benjamin
Jan 1, 1995·NeuroRehabilitation·J Bogner, J D Corrigan
Jul 28, 2015·Archives of Physical Medicine and Rehabilitation·Jennifer BognerWilliam Garmoe

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
medical procedure

Software Mentioned

Stata
Epworth
Medical Decision Maker
SAS

Related Concepts

Related Feeds

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here